Company Filing History:
Years Active: 2012
Title: Benjamin Garfield Perry: Innovator in Kinase Inhibitors
Introduction
Benjamin Garfield Perry is a notable inventor based in Slough, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. His work is aimed at addressing various medical conditions, showcasing the impact of his innovations on healthcare.
Latest Patents
Perry holds a patent for "Fused thiazole derivatives as kinase inhibitors." This patent includes a series of 6,7-dihydro[1,3]thiazolo[5,4-c]pyridin-4(5H)-one derivatives, which are selectively designed to inhibit PI3 kinase enzymes. These compounds are beneficial in treating inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive, or ophthalmic conditions. His innovative approach in this area has the potential to lead to new therapeutic options.
Career Highlights
Perry is currently associated with UCB Pharma, S.A., where he continues to advance his research and development efforts. His work at UCB Pharma has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.
Collaborations
Among his coworkers are Rikki Peter Alexander and Pavandeep Singh Aujla. Their collaboration contributes to a dynamic research environment, fostering innovation and the development of new therapeutic solutions.
Conclusion
Benjamin Garfield Perry is a distinguished inventor whose work in kinase inhibitors is paving the way for advancements in medical treatments. His contributions are vital in addressing complex health issues, and his ongoing research promises to yield further innovations in the field.